198 related articles for article (PubMed ID: 17578827)
1. Bone mineral density and bone turnover in hyperprolactinaemia of various origins.
Zadrozna-Sliwka B; Bolanowski M; Kałuzny M; Syrycka J
Endokrynol Pol; 2007; 58(2):116-22. PubMed ID: 17578827
[TBL] [Abstract][Full Text] [Related]
2. The influence of other than prolactin hormones on bone mineral density in women with hyperprolactinaemia of various origins.
Bolanowski M; Zadrozna-Sliwka B; Jawiarczyk A; Syrycka J
Gynecol Endocrinol; 2010 Aug; 26(8):623-7. PubMed ID: 20218822
[TBL] [Abstract][Full Text] [Related]
3. Prolactinomas in adolescents: persistent bone loss after 2 years of prolactin normalization.
Colao A; Di Somma C; Loche S; Di Sarno A; Klain M; Pivonello R; Pietrosante M; Salvatore M; Lombardi G
Clin Endocrinol (Oxf); 2000 Mar; 52(3):319-27. PubMed ID: 10718830
[TBL] [Abstract][Full Text] [Related]
4. The role of cyclase activating (CAP) and cyclase inhibiting (CIP) parathormone fractions in the assessment of bone metabolism disturbances in women with hyperprolactinemia of various origin.
Zadrozna-Sliwka B; Bolanowski M; Jawiarczyk A; Kaluzny M; Syrycka J
Neuro Endocrinol Lett; 2008 Feb; 29(1):178-84. PubMed ID: 18283239
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and magnitude of osteopenia in patients with prolactinoma.
Kayath MJ; Lengyel AM; Vieira JG
Braz J Med Biol Res; 1993 Sep; 26(9):933-41. PubMed ID: 8298528
[TBL] [Abstract][Full Text] [Related]
6. [Decreased bone mineral density in pre-menopause women with prolactinoma].
Bussade I; Naliato EC; Mendonça LM; Violante AH; Farias ML
Arq Bras Endocrinol Metabol; 2007 Dec; 51(9):1522-7. PubMed ID: 18209896
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of osteopenia in men with prolactinoma.
Naliato EC; Farias ML; Braucks GR; Costa FS; Zylberberg D; Violante AH
J Endocrinol Invest; 2005 Jan; 28(1):12-7. PubMed ID: 15816365
[TBL] [Abstract][Full Text] [Related]
8. Hyperprolactinaemia associated with increased thyroid volume and autoimmune thyroiditis in patients with prolactinoma.
Sayki Arslan M; Sahin M; Topaloglu O; Tutal E; Karakose M; Gungunes A; Cakal E; Ozbek M; Delibasi T
Clin Endocrinol (Oxf); 2013 Dec; 79(6):882-6. PubMed ID: 23551036
[TBL] [Abstract][Full Text] [Related]
9. Bone remodeling and bone mineral density during pregnancy.
Ulrich U; Miller PB; Eyre DR; Chesnut CH; Schlebusch H; Soules MR
Arch Gynecol Obstet; 2003 Oct; 268(4):309-16. PubMed ID: 14504876
[TBL] [Abstract][Full Text] [Related]
10. [Hyperprolactinaemia and bone mineral density].
Kostrzak A; Męczekalski B
Pol Merkur Lekarski; 2015 Aug; 39(230):122-5. PubMed ID: 26319389
[TBL] [Abstract][Full Text] [Related]
11. Bones and Crohn's: estradiol deficiency in men with Crohn's disease is not associated with reduced bone mineral density.
Klaus J; Reinshagen M; Adler G; Boehm B; von Tirpitz C
BMC Gastroenterol; 2008 Oct; 8():48. PubMed ID: 18947388
[TBL] [Abstract][Full Text] [Related]
12. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis.
Garnero P; Sornay-Rendu E; Chapuy MC; Delmas PD
J Bone Miner Res; 1996 Mar; 11(3):337-49. PubMed ID: 8852944
[TBL] [Abstract][Full Text] [Related]
13. Additional beneficial effects of alendronate in growth hormone (GH)-deficient adults with osteoporosis receiving long-term recombinant human GH replacement therapy: a randomized controlled trial.
Biermasz NR; Hamdy NA; Janssen YJ; Roelfsema F
J Clin Endocrinol Metab; 2001 Jul; 86(7):3079-85. PubMed ID: 11443170
[TBL] [Abstract][Full Text] [Related]
14. Vertebral fractures in males with prolactinoma.
Mazziotti G; Porcelli T; Mormando M; De Menis E; Bianchi A; Mejia C; Mancini T; De Marinis L; Giustina A
Endocrine; 2011 Jun; 39(3):288-93. PubMed ID: 21479837
[TBL] [Abstract][Full Text] [Related]
15. [The role of biochemical markers of bone turnover in the diagnosis of osteoporosis and predicting fracture risk].
Mohamed Y; Haifa H; Datel O; Fadoua HN; Smeh BH; Mahbouba J; Saoussen Z; Bejia I; Mongi T; Mohamed FN; Naceur B
Tunis Med; 2014 May; 92(5):304-10. PubMed ID: 25504382
[TBL] [Abstract][Full Text] [Related]
16. Changes in bone mass and bone turnover following distal forearm fracture.
Ingle BM; Hay SM; Bottjer HM; Eastell R
Osteoporos Int; 1999; 10(5):399-407. PubMed ID: 10591838
[TBL] [Abstract][Full Text] [Related]
17. Effect of walking exercise on bone metabolism in postmenopausal women with osteopenia/osteoporosis.
Yamazaki S; Ichimura S; Iwamoto J; Takeda T; Toyama Y
J Bone Miner Metab; 2004; 22(5):500-8. PubMed ID: 15316873
[TBL] [Abstract][Full Text] [Related]
18. Longitudinal changes in bone mineral density and bone turnover in postmenopausal women with primary hyperparathyroidism.
Guo CY; Thomas WE; al-Dehaimi AW; Assiri AM; Eastell R
J Clin Endocrinol Metab; 1996 Oct; 81(10):3487-91. PubMed ID: 8855790
[TBL] [Abstract][Full Text] [Related]
19. Role of type I collagen C telopeptide, bone-specific alkaline phosphatase and osteocalcin in the assessment of bone status in postmenopausal women.
Trento LK; Pietropolli A; Ticconi C; Gravotta E; De Martino MU; Fabbri A; Piccione E
J Obstet Gynaecol Res; 2009 Feb; 35(1):152-9. PubMed ID: 19215563
[TBL] [Abstract][Full Text] [Related]
20. Relationship between bone turnover and bone density at the proximal femur in stroke patients.
Paker N; Bugdayci D; Tekdos D; Dere C; Kaya B
J Stroke Cerebrovasc Dis; 2009; 18(2):139-43. PubMed ID: 19251190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
